241 related articles for article (PubMed ID: 24057763)
1. Effect of alpha7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats.
Jones KM; McDonald IM; Bourin C; Olson RE; Bristow LJ; Easton A
Psychopharmacology (Berl); 2014 Feb; 231(4):673-83. PubMed ID: 24057763
[TBL] [Abstract][Full Text] [Related]
2. Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats.
Callahan PM; Terry AV; Tehim A
Psychopharmacology (Berl); 2014 Sep; 231(18):3695-706. PubMed ID: 24595504
[TBL] [Abstract][Full Text] [Related]
3. α7 nicotinic receptor agonist and positive allosteric modulators differently improved schizophrenia-like cognitive deficits in male rats.
Unal G; Sirvanci S; Aricioglu F
Behav Brain Res; 2021 Jan; 397():112946. PubMed ID: 33011186
[TBL] [Abstract][Full Text] [Related]
4. Alpha 7 nicotinic receptor agonist and positive allosteric modulators improved social and molecular deficits of MK-801 model of schizophrenia in rats.
Unal G; Bekci H; Cumaoglu A; Yerer MB; Aricioglu F
Pharmacol Biochem Behav; 2020 Jun; 193():172916. PubMed ID: 32220620
[TBL] [Abstract][Full Text] [Related]
5. 3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats.
Potasiewicz A; Hołuj M; Kos T; Popik P; Arias HR; Nikiforuk A
Neuropharmacology; 2017 Feb; 113(Pt A):188-197. PubMed ID: 27717880
[TBL] [Abstract][Full Text] [Related]
6. Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study.
Marcus MM; Björkholm C; Malmerfelt A; Möller A; Påhlsson N; Konradsson-Geuken Å; Feltmann K; Jardemark K; Schilström B; Svensson TH
Eur Neuropsychopharmacol; 2016 Sep; 26(9):1401-1411. PubMed ID: 27474687
[TBL] [Abstract][Full Text] [Related]
7. Subtype-selective nicotinic acetylcholine receptor agonists can improve cognitive flexibility in an attentional set shifting task.
Wood C; Kohli S; Malcolm E; Allison C; Shoaib M
Neuropharmacology; 2016 Jun; 105():106-113. PubMed ID: 26772970
[TBL] [Abstract][Full Text] [Related]
8. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia.
Pichat P; Bergis OE; Terranova JP; Urani A; Duarte C; Santucci V; Gueudet C; Voltz C; Steinberg R; Stemmelin J; Oury-Donat F; Avenet P; Griebel G; Scatton B
Neuropsychopharmacology; 2007 Jan; 32(1):17-34. PubMed ID: 16936709
[TBL] [Abstract][Full Text] [Related]
9. Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914/SEN34625.
Marquis KL; Comery TA; Jow F; Navarra RL; Grauer SM; Pulicicchio C; Kelley C; Brennan JA; Roncarati R; Scali C; Haydar S; Ghiron C; Terstappen GC; Dunlop J
Psychopharmacology (Berl); 2011 Dec; 218(4):635-47. PubMed ID: 21643676
[TBL] [Abstract][Full Text] [Related]
10. TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia.
Hauser TA; Kucinski A; Jordan KG; Gatto GJ; Wersinger SR; Hesse RA; Stachowiak EK; Stachowiak MK; Papke RL; Lippiello PM; Bencherif M
Biochem Pharmacol; 2009 Oct; 78(7):803-12. PubMed ID: 19482012
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats.
Potasiewicz A; Nikiforuk A; Hołuj M; Popik P
J Psychopharmacol; 2017 Feb; 31(2):260-271. PubMed ID: 28168926
[TBL] [Abstract][Full Text] [Related]
12. The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats.
Hajós M; Hurst RS; Hoffmann WE; Krause M; Wall TM; Higdon NR; Groppi VE
J Pharmacol Exp Ther; 2005 Mar; 312(3):1213-22. PubMed ID: 15523001
[TBL] [Abstract][Full Text] [Related]
13. Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia.
Barak S; Arad M; De Levie A; Black MD; Griebel G; Weiner I
Neuropsychopharmacology; 2009 Jun; 34(7):1753-63. PubMed ID: 19158670
[TBL] [Abstract][Full Text] [Related]
14. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
[TBL] [Abstract][Full Text] [Related]
15. Alpha-7 nicotinic acetylcholine receptor agonists selectively activate limbic regions of the rat forebrain: an effect similar to antipsychotics.
Hansen HH; Timmermann DB; Peters D; Walters C; Damaj MI; Mikkelsen JD
J Neurosci Res; 2007 Jun; 85(8):1810-8. PubMed ID: 17455307
[TBL] [Abstract][Full Text] [Related]
16. Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.
McLean SL; Grayson B; Idris NF; Lesage AS; Pemberton DJ; Mackie C; Neill JC
Eur Neuropsychopharmacol; 2011 Apr; 21(4):333-43. PubMed ID: 20630711
[TBL] [Abstract][Full Text] [Related]
17. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats.
Nikiforuk A; Kos T; Hołuj M; Potasiewicz A; Popik P
Neuropharmacology; 2016 Feb; 101():389-400. PubMed ID: 26232639
[TBL] [Abstract][Full Text] [Related]
18. Chronic nicotine and dizocilpine effects on nicotinic and NMDA glutamatergic receptor regulation: interactions with clozapine actions and attentional performance in rats.
Rezvani AH; Tizabi Y; Getachew B; Hauser SR; Caldwell DP; Hunter C; Levin ED
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1030-40. PubMed ID: 18343006
[TBL] [Abstract][Full Text] [Related]
19. Cognitive improvements in a mouse model with substituted 1,2,3-triazole agonists for nicotinic acetylcholine receptors.
Arunrungvichian K; Boonyarat C; Fokin VV; Taylor P; Vajragupta O
ACS Chem Neurosci; 2015 Aug; 6(8):1331-40. PubMed ID: 25978789
[TBL] [Abstract][Full Text] [Related]
20. Nicotine and clozapine effects on attentional performance impaired by the NMDA antagonist dizocilpine in female rats.
Rezvani AH; Kholdebarin E; Dawson E; Levin ED
Int J Neuropsychopharmacol; 2008 Feb; 11(1):63-70. PubMed ID: 17295931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
